Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.010 | GeneticVariation | BEFREE | <b>Methods</b>: The Therapeutic Advances in Childhood Leukemia and Lymphoma Phase I consortium performed a pilot study on 3 patients with MRD positive acute leukemia after an initial remission on conventional chemotherapy (TACL T2009-008) with the TLR 9 agonist (GNKG168). | 31530240 | 2019 |
||||||||
|
|
0.020 | GeneticVariation | BEFREE | <i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy? | 31671855 | 2019 |
||||||||
|
|
0.020 | GeneticVariation | BEFREE | <i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy? | 31671855 | 2019 |
||||||||
|
|
0.020 | GeneticVariation | BEFREE | <i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy? | 31671855 | 2019 |
||||||||
|
|
0.020 | GeneticVariation | BEFREE | <i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy? | 31671855 | 2019 |
||||||||
|
|
0.020 | GeneticVariation | BEFREE | <i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy? | 31671855 | 2019 |
||||||||
|
|
0.020 | GeneticVariation | BEFREE | <i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy? | 31671855 | 2019 |